At a glance
- Originator National Defense Medical Center; Taipei Veterans General Hospital
- Class Nucleosides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 07 Feb 1995 Preclinical development for Transplant rejection in China (Unknown route)